Literature DB >> 24827543

Prevalence of eosinophilic esophagitis in a United States military health-care population.

M R Ally1,2, C L Maydonovitch1, J D Betteridge1,2, G R Veerappan1,2, F J Moawad1,2.   

Abstract

Eosinophilic esophagitis (EoE) is a rapidly emerging chronic immune-mediated condition affecting children and adults, both genders, and all races. A large variation in the prevalence of EoE exists in the literature. The aim of this study is to establish the prevalence of EoE in a military health-care population in the United States using a comprehensive electronic medical record search. Using the International Classification for Diseases-9 code for EoE (530.13), the total number of EoE patients enrolled in the military health-care system from October 1, 2008 to September 30, 2009 including active-duty military, dependents of military personnel, and retirees were identified. For each case of EoE identified, demographic data (age, gender, and race) and geographic location was obtained. The overall prevalence of EoE was calculated as well as the prevalence within subgroups. The geographic regional locations were reported per the U.S. Census Bureau regions (Northeast, South, Midwest, and West). A total of 987 EoE patients were identified from 10,180,515 military health-care beneficiaries, establishing an overall prevalence of 9.7 per 100,000 (95% confidence interval [CI] 9.1-10.3). Seven hundred twenty-eight out of 7,707,372 adult patients were identified, establishing a prevalence of 9.5 per 100,000 (95% CI 8.8-10.1). Two hundred fifty-nine out of 2,473,143 pediatric patients were identified, establishing a prevalence of 10.5/100,000 (95% CI 9.2-11.8). EoE was more prevalent in males (odds ratio [OR] 2.03 [95% CI 1.78-2.32]) and higher in Caucasian versus African Americans (18.1 vs. 5.2/100,000, OR 3.47 [95% CI 2.40-5.03]). EoE was more prevalent in the Western region of the United States compared with the Northeast, South, and Midwest regions, with a prevalence of 11.9 versuss 5.2, 9.6, and 9.2 per 100,000, respectively. When comparing Northern with Southern states, there was an increased prevalence in the North (10.9 vs. 7.2/100,000, P < 0.05). In this large nationwide study, increase in prevalence of EoE was seen in younger adults, with a higher prevalence in Caucasians. Geographically, the western United States had a significantly higher prevalence with a slightly higher prevalence in the Northern latitude. Published 2014. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  eosinophilic esophagitis; epidemiology; geographic location; prevalence; race

Mesh:

Year:  2014        PMID: 24827543     DOI: 10.1111/dote.12229

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  10 in total

Review 1.  Epidemiology and Natural History of Eosinophilic Esophagitis.

Authors:  Evan S Dellon; Ikuo Hirano
Journal:  Gastroenterology       Date:  2017-08-01       Impact factor: 22.682

Review 2.  Eosinophilic Esophagitis Clinical Manifestations and Differential Diagnosis.

Authors:  Diana Muñoz-Mendoza; Adrián Chapa-Rodríguez; Sami L Bahna
Journal:  Clin Rev Allergy Immunol       Date:  2018-08       Impact factor: 8.667

Review 3.  Eosinophilic Esophagitis From an Allergy Perspective: How to Optimally Pursue Allergy Testing & Dietary Modification in the Adult Population.

Authors:  Emily C McGowan; Thomas A Platts-Mills
Journal:  Curr Gastroenterol Rep       Date:  2016-11

4.  Increasing incidence of eosinophilic esophagitis in Sweden: a nationwide population study.

Authors:  John J Garber; Paul J Lochhead; Amiko M Uchida; Bjorn Roelstraete; David Bergman; Mark S Clements; Jonas F Ludvigsson
Journal:  Esophagus       Date:  2022-06-02       Impact factor: 3.671

5.  The 2010-2015 Prevalence of Eosinophilic Esophagitis in the USA: A Population-Based Study.

Authors:  Emad Mansoor; Gregory S Cooper
Journal:  Dig Dis Sci       Date:  2016-06-01       Impact factor: 3.199

6.  Correction to: Eosinophilic esophagitis.

Authors:  Stuart Carr; Edmond S Chan; Wade Watson
Journal:  Allergy Asthma Clin Immunol       Date:  2019-04-10       Impact factor: 3.406

7.  Delayed hypersensitivity reaction to orodispersible budesonide in a case with eosinophilic esophagitis.

Authors:  Caroline Michèle Andrist; Lukas Jörg; Thomas Greuter; Anna Gschwend; Alex Straumann; Arthur Helbling
Journal:  BMC Gastroenterol       Date:  2020-12-11       Impact factor: 3.067

8.  Eosinophilic gastrointestinal disorder: is it what it seems to be?

Authors:  Stefania Chetcuti Zammit; Monique Cachia; Karen Sapiano; Julia Gauci; Stephen Montefort; Pierre Ellul
Journal:  Ann Gastroenterol       Date:  2018-04-27

Review 9.  Eosinophilic esophagitis.

Authors:  Stuart Carr; Edmond S Chan; Wade Watson
Journal:  Allergy Asthma Clin Immunol       Date:  2018-09-12       Impact factor: 3.406

10.  Natural history of eosinophilic esophagitis: a systematic review of epidemiology and disease course.

Authors:  N J Shaheen; V Mukkada; C S Eichinger; H Schofield; L Todorova; G W Falk
Journal:  Dis Esophagus       Date:  2018-08-01       Impact factor: 3.429

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.